P

    PharmaCyte Biotech Inc (PMCB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.50
    -0.01 (-2.74%)

    Market Cap: $5.53M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    64%(7/11)
    Avg Surprise
    -37.06%
    Streak
    1 Q
    PeriodReportedEst.SurpriseB/MYoY
    Apr 26
    Reported Jul 1
    		$-0.01N/AN/ABeat-100.6%
    Jan 26
    Reported Mar 17
    		$-0.17$0.00N/AMiss+61.6%
    Oct 25
    Reported Dec 18
    		$-1.24$0.00N/AMiss-220.1%
    Jul 25
    Reported Aug 11
    		$-1.23$0.00N/AMiss-164.7%
    Apr 25
    Reported Jul 2
    		$1.58$0.00N/ABeat+599.8%
    Jan 25
    Reported Mar 17
    		$-0.44N/AN/ABeat-525.0%
    Oct 24
    Reported Dec 13
    		$-0.39N/AN/ABeat-50.4%
    Jul 24
    Reported Aug 13
    		$1.90$0.00N/ABeat+784.0%
    Apr 24
    Reported Jul 29
    		$-0.32$0.00N/ABeat-4114.7%
    Jan 24
    Reported Mar 18
    		$-0.07$-0.07+0.00%Beat-74.1%
    Oct 23
    Reported Dec 15
    		$-0.26$-0.08-222.00%Miss-181.8%
    Jul 23
    Reported Sep 18
    		$-0.28$-0.07-297.14%Miss-297.1%
    Apr 23
    Reported Jul 31
    		$-0.01N/A+91.67%Beat+87.5%
    Jan 23
    Reported Mar 16
    		$-0.04$-0.08+49.75%Beat-0.5%
    Oct 22
    Reported Dec 14
    		$-0.09$-0.08-14.25%Miss-52.3%
    Jul 22
    Reported Sep 14
    		$-0.07$-0.07+0.00%Beat+89.1%
    Apr 22
    Reported Jul 28
    		$-0.06$-0.04-50.00%Miss+90.7%
    Jan 22
    Reported Mar 15
    		$-0.04$-0.05+20.00%Beat+93.4%
    Oct 21
    Reported Dec 14
    		$-0.06$-0.07+14.29%Beat+87.7%
    Jul 21
    Reported Aug 10
    		$-0.64$-0.64+0.00%Beat-3.7%
    Apr 21
    Reported Jun 30
    		$-0.64N/AN/ABeat+18.4%
    Jan 21
    Reported Mar 12
    		$-0.61N/AN/ABeat+15.1%
    Oct 20
    Reported Dec 11
    		$-0.49N/AN/ABeat+49.1%
    Jul 20
    Reported Aug 13
    		$-0.62N/AN/ABeat+48.9%
    Apr 20
    Reported Jul 1
    		$-0.79N/AN/ABeat+43.8%
    Jan 20
    Reported Mar 13
    		$-0.72N/AN/ABeat+51.8%
    Oct 19
    Reported Dec 23
    		$-0.95N/AN/ABeat-6.0%
    Jul 19
    Reported Aug 12
    		$-1.21N/AN/ABeat+16.0%
    Apr 19
    Reported Jul 3
    		$-1.41N/AN/ABeat+19.3%
    Jan 19
    Reported Mar 14
    		$-1.49N/AN/ABeat+23.4%
    Oct 18
    Reported Dec 14
    		$-0.90N/AN/ABeat+71.2%
    Jul 18
    Reported Sep 12
    		$-1.44N/AN/ABeat+48.5%
    Apr 18
    Reported Jul 20
    		$-1.74N/AN/ABeat+36.3%
    Jan 18
    Reported Mar 19
    		$-1.94N/AN/ABeat+77.8%
    Oct 17
    Reported Dec 14
    		$-3.12N/AN/ABeat-39.5%
    Jul 17
    Reported Sep 13
    		$-2.80N/AN/ABeat-
    Apr 17
    Reported Jul 27
    		$-2.74N/AN/ABeat-
    Jan 17
    Reported Mar 13
    		$-8.76N/AN/ABeat-
    Oct 16
    Reported Dec 2
    		$-2.24N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.19EV/EBITDA-12.02x
    Price/FCF-0.90xFCF Yield-111.06%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-44.70%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio12.33xQuick Ratio12.33x
    Trading Statistics
    Beta0.68Avg Volume96.72K
    52-Week High$1.5152-Week Low$0.48

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.53
    SMA 20$0.55
    SMA 50$0.62
    SMA 200$0.74
    EMA 10$0.53
    EMA 20$0.55
    EMA 50$0.61
    EMA 200$0.76

    MACD

    Line: -0.03Signal: -0.03Hist: 0.00

    ADX

    ADX: 45.6+DI: 7.9-DI: 24.4

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$0.56

    Bollinger Bands

    Upper Band$0.60
    Lower Band$0.49
    %B Position2010%(Upper)
    Band Width0.09

    RSI (14-Day)

    Neutral
    31.0

    Momentum Oscillators

    Stoch %K23.8
    Stoch %D29.9
    Williams %R-79.6
    ROC (10d)-7.6%
    Momentum-0.04
    CCI (20d)-131.4
    MFI (14d)31.9

    Volatility Measures

    ATR (14d)$0.04(7.4%)
    StdDev (20d)0.03
    Hist Vol44.8%(High)

    Volume Flow

    VWAP$0.50
    OBV188.8M
    AD Line-17.9M
    CMF (20d)-0.049

    Volume Metrics

    Avg Vol (20d)95.0K
    Vol Ratio1.1x
    VWMA (20d)$0.55

    Pivot Points

    R3$0.56
    R2$0.55
    R1$0.53
    Pivot Point$0.52
    S1$0.50
    S2$0.49
    S3$0.47

    Advanced Oscillators

    TSI-31.67
    Ultimate Osc48.7
    KST-154.17

    Financial Data

    QuarterJan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023Jul 2023Apr 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$0$0
    Cost of Revenue$0$0$0$-905,680$0$0$0$-1,089,934$620,777$229,159$239,998$255,262
    Gross Profit$0$0$0$905,680$0$0$0$1.09M$-620,777$-229,159$-239,998$-255,262
    Operating Expenses$2.12M$1.38M$848,305$1.95M$960,252$1.11M$1.27M$4.26M$1.25M$1.18M$1.84M$648,021
    R&D$93,113$141,085$95,157$126,734$118,196$97,470$96,016$94,183$126,732$82,033$104,483$85,874
    SG&A$2.02M$1.23M$753,148$2.24M$842,056$1.01M$1.17M$3.16M$482,675$791,590$1.68M$561,831
    Operating Income$-2,118,102$-1,376,051$-848,305$-1,042,663$-960,252$-1,106,060$-1,268,887$-3,166,216$-1,868,946$-1,409,520$-2,075,326$-903,283
    Interest Income$230,668$206,387$217,793$229,875$255,692$382,562$547,432$747,098$881,662$894,181$875,878$722,937
    Interest Expense$0$6.04M$7.51M$0$2.09M$363,500$0$0$0$0$1.11M$0
    Income Before Tax$746,860$-7,417,975$-8,360,096$11.75M$-3,045,328$-1,469,560$23.42M$1.35M$-619,537$2.79M$-3,183,297$-126,338
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$746,860$-7,417,975$-8,360,096$11.75M$-3,045,328$-1,469,560$23.42M$1.35M$-619,537$2.79M$-3,183,297$-126,338
    EBITDA$516,192$-7,624,362$-8,577,889$11.52M$-3,301,020$-1,852,122$22.87M$599,603$-1,501,199$1.90M$-4,059,175$-849,275
    EBIT$516,192$-7,624,362$-8,577,889$11.52M$-3,301,020$-1,852,122$22.87M$599,603$-1,501,199$1.90M$-4,059,175$-849,275
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PMCB

    News

    PharmaCyte Biotech | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Abecassis Michael M - moomoo

    This article is a Form 4/A filing from PharmaCyte Biotech, detailing a statement of changes in beneficial ownership of securities for Director Michael M. Abecassis. The document itself would contain the specific transaction details.

    Moomoo•8/22/26•
    Neutral

    PharmaCyte Biotech | 10-K: FY2026 Annual Report

    This article is a 10-K Annual Report filing for PharmaCyte Biotech for the fiscal year 2026. The 10-K report contains comprehensive financial performance details for the company during the stated fiscal year.

    Moomoo•8/22/26•
    Neutral

    PharmaCyte Biotech Inc (PMCB) Stock News Today

    This article provides current stock information for PharmaCyte Biotech Inc (PMCB), including its latest stock price, daily change, market cap, and links to financial data, analyst ratings, and news. As of the report, PMCB closed at $0.553 with a 1.37% increase, and indicated that more news about the company is expected soon. The platform "TradingKey" serves as the source for this investment data.

    TradingKey•8/9/26•
    Neutral

    PharmaCyte Biotech Inc (PMCB) Earnings Forecast: Future EPS & Revenue Growth Estimates

    This article provides an earnings forecast for PharmaCyte Biotech Inc (PMCB), detailing future EPS and revenue growth estimates. It includes a snapshot of the company's current stock price, market capitalization, and various financial metrics. The article also lists peer comparisons and indicates that the financial forecasting data was updated on August 7, 2026.

    TradingKey•8/8/26•
    Neutral

    PharmaCyte Biotech Inc (PMCB) Technical Analysis: Support, Resistance, Indicators & Moving Averages

    This article provides a technical analysis of PharmaCyte Biotech Inc (PMCB), detailing its current price momentum score, support and resistance levels, and indicator and moving average assessments. It highlights that PMCB's stock price is currently trading between a resistance level of 0.71 and a support level of 0.49, suggesting suitability for range-bound swing trading. The analysis also summarizes various technical indicators and moving averages, with a current overall neutral signal.

    TradingKey•7/30/26•
    Somewhat-Bearish

    Frequently Asked Questions About PMCB

    Does PMCB pay dividends?
    PharmaCyte Biotech Inc (PMCB) does not currently pay a regular dividend.
    What is PMCB's market cap?
    PharmaCyte Biotech Inc (PMCB) has a market capitalization of $5.53M with a current stock price of $0.50.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In